LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE585.40-7.35 (-1.24 %)
PREV CLOSE ( ) 592.75
OPEN PRICE ( ) 596.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2180
TODAY'S LOW / HIGH ( )582.50 600.90
52 WK LOW / HIGH ( )328.75 754.25
NSE586.05-7.1 (-1.2 %)
PREV CLOSE( ) 593.15
OPEN PRICE ( ) 598.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 586.05 (2)
VOLUME 39144
TODAY'S LOW / HIGH( ) 582.10 603.85
52 WK LOW / HIGH ( )329.55 755.15
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax1004.80959.39837.21672.32621.95
Adjustment-2.3514.8548.3686.6293.02
Changes In working Capital-313.7424.052.04143.31-11.18
Cash Flow after changes in Working Capital688.72998.28887.61902.25703.79
Cash Flow from Operating Activities392.62761.32692.70754.15528.45
Cash Flow from Investing Activities-366.43-780.80-642.27-308.83-181.88
Cash Flow from Financing Activities-45.01-25.56-57.45-377.59-357.68
Net Cash Inflow / Outflow-18.82-45.04-7.0367.74-11.11
Opening Cash & Cash Equivalents69.34114.38121.4154.5765.68
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent50.5269.34114.38122.3154.57

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.